摘要
目的分析李成纲教授清金麦茎方治疗老年非小细胞肺癌(NSCLC)的临床效果及对患者免疫抑制状态的影响。方法选取老年NSCLC患者90例,随机分为对照组和观察组,各45例。对照组予以常规方案化疗干预,观察组在对照组基础上增加李成纲教授清金麦茎方治疗,比较两组不同治疗方案的临床疗效、药物毒性反应发生情况、免疫功能、血清因子水平及生活质量(QLQ-30)。结果观察组临床疗效高于对照组(P<0.05);观察组药物毒性反应发生情况较对照组明显减轻(P<0.05);两组免疫功能对比,观察组CD3+、CD4+、CD4+/CD8+水平较对照组均有明显升高(P<0.001);观察组血清TGF-β、IL-6水平均低于对照组(P<0.001);两组QLQ-30评分对比,观察组功能及健康领域评分均高于对照组,症状评分显著低于对照组(P<0.001)。结论应用清金麦茎方治疗老年NSCLC效果显著,可有效改善患者免疫抑制状态,且安全性高,值得推广。
Objective To analyze the impact of Professor Li Chenggang’s Qingjin Maiqin TCM prescriptions on the curative effects and immunosuppression states of elderly non-small cell lung cancer(NSCLC)patients.Methods 90 elderly NSCLC patients in our hospital were selected as research subjects.According to random number table,patients were divided into control group(n=45,conventional chemotherapy)and observation group(n=45,conventional chemotherapy and Professor Li Chenggang’s Qingjin Maiqin TCM prescriptions).Clinical effectiveness,drug toxicity,immune function,serum factors and quality of life questionnaire-30(QLQ-30)scores were compared.Results Clinical effective rate in the observation group was higher than control group(P<0.05).The drug toxic reaction rate in the observation group was significantly lower than control group(P<0.05).CD3+,CD4+and CD4+/CD8+values in the observation group were significantly higher than control group(P<0.001).Serum factors like serum TGF-β(transforming growth factor-β)and IL-6(interleukin-6)levels in the observation group were lower than control group(P<0.001).The functional and health assessment scores in the observation group were higher than control group,but clinical symptom scores were lower than control group(P<0.001).Conclusion Qingjin Maiqin TCM prescriptions can effectively improve the immunosuppression states and treatment safety for elderly NSCLC patients.
作者
谢青
郭宏
高龙
冯寿钰
李婕
徐文江
Xie Qing;Guo Hong;Gao Long;Feng Shouyu;Li Jie;Xu Wenjiang(Pulmonary and Critical Care Medicine Department,Baoji City TCM Hospital,Baoji 721000,Shanxi,China;Cardiovascular Pediatrics Department,Baoji City TCM Hospital,Baoji 721000,Shanxi,China;Emergency Department,Baoji City TCM Hospital,Baoji 721000,Shanxi,China;Proctology Department,Baoji City TCM Hospital,Baoji 721000,Shanxi,China;Oncological Hematology Department,Baoji City TCM Hospital,Baoji 721000,Shanxi,China)
出处
《贵州医药》
CAS
2022年第10期1520-1522,共3页
Guizhou Medical Journal
基金
宝鸡市卫生健康委员会科研项目(2019-41)。
关键词
老年非小细胞肺癌
清金麦茎方
免疫抑制
毒性反应
生活质量
Non-small cell lung cancer
Qingjin Maiqin TCM prescriptions
Immunosuppression
Toxic reaction
Quality of life